Products

Latest press and releases on orthopaedic products, devices, implants and services.

By Kelly M. Pyrek Mobile devices are ubiquitous in society and their infiltration of the healthcare environment poses new challenges for infection prevention and control. Numerous studies have documented that mobile handheld devices are frequently contaminated with healthcare-associated pathogens, but they are seldom cleaned and disinfected due to individuals being unsure of what kind of products and methods to use to decontaminate their electronics. Manning, et al. (2013) emphasize that "It is imperative that infection prevention and control programs be actively engaged in providing healthcare worker (HCW) guidance and education in how to mitigate the risk of bacterial contamination of their mobile health devices (MHDs).

Read more ...

Caesarea, Israel-based Mazor Robotics' full-year 2016 revenue rose 39 percent to $36.4 million, up from $26.1 million in 2015. Plainsboro, N.J.-based Integra LifeSciences made a binding offer to acquire Johnson & Johnson's Codman Neurosurgery business, based in Raynham, Mass. Huntley, Ill-based Life Spine reported 2016 revenues increased by 38 percent from 2015 revenues. The Economic Development Growth Engine for Memphis and Shelby County board approved a $9 million, 11-year payment-in-lieu-of-taxes incentive for San Diego-based NuVasive to create new jobs in the area. Malden, Mass.-based AxioMed reported positive results for the first patient undergoing a viscoelastic four-level cervical procedure. Visit Original Source

Thornton Cleveleys, UK (PRWEB)January 17, 2017 Early clinical results presented by surgeons at the 2016 annual meeting of the North American Spine Society (NASS)1 demonstrate high fusion rates at 6 months and beneficial clinical outcomes, for patients in the majority of cases, when PEEK-OPTIMA™ HA Enhanced is used for interbody-fusion devices. The implantable high-performance polymer, from Invibio Biomaterial Solutions, uniquely combines PEEK-OPTIMA, the principal PEEK-based biomaterial with over 15 years of proven history in clinical use, and hydroxyapatite (HA), a well-known osteoconductive material that enhances bone apposition, and is fully integrated. Previous studies by Invibio have highlighted that enhancing bone apposition on all surfaces of an interbody-fusion device may offer better integration and improved potential for spinal fusion.

Read more ...

Lima Corporate is very proud to announce the arrival of a new Advisory Board Member UDINE, Italy, Jan. 16, 2017 /CNW/ - Starting January 1st, Mr. Bruno A. Melzi has joined the Lima organization as an Advisory Board Member. Mr. Melzi joined Zimmer Inc. in 1990 as Managing Director for Italy, from 1997 to 2000 he served as Vice President Europe to become President for EMEA from 2000 to 2003. From this year till 2005 he was Chairman International EMEA & Japan with the direct report of finance, human resources, legal and communications functions. From 2005 to 2013 Mr. Melzi was Chairman for Zimmer EMEA.

Read more ...

The Indian medical device industry is disarray. Even industry representatives admit so. For instance, Rajiv Nath, the forum coordinator of the Association of Indian Medical Device Industry, goes so far as to state that the sector is “in a state of complete mess”. That’s because about 99% of medical devices such as ultrasound machines, glucometers, endoscopes and ventilators are not regulated by the government. To remedy this, the Ministry of Health and Family Welfare in October made a revised draft of the Medical Device Rules public for comment. However, though there are over 5,000 kinds of medical devices in the market, the draft rules cover only about 20 devices – stents, orthopedic implants, ocular lenses, condoms, sutures and surgical dressings – that have been notified under the Drugs and Cosmetics Act, 1940.

Read more ...

BELGRADE, Mont., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced that it has entered into an agreement with certain holders of its convertible promissory notes (“Indenture Notes”) to purchase shares of Xtant's common stock in a registered direct offering conducted without an underwriter or placement agent (the "Offering"). All of the proceeds of the Offering will be applied to set off interest owed by Xtant under certain of the Indenture Notes to the purchasers of the common stock.

Read more ...

 A 3D scaffold has been molded into the precise shape of a hip joint. The scaffold is covered with cartilage made from stem cells taken from fat beneath the skin. (Credit: Guilak laboratory)Scientists are developing a way to treat arthritic hips without extensive surgery to replace them. They’ve programmed stem cells to grow new cartilage on a 3D template shaped like the ball of a hip joint. What’s more, using gene therapy, they have activated the new cartilage to release anti-inflammatory molecules to fend off a return of arthritis. The discovery may one day provide an alternative to hip-replacement surgery, particularly in younger patients.

Read more ...

Future Market Insights has announced the addition of the “Orthopaedic Oncology Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering. Orthopaedic Oncology Market PR-Inside.com: 2017-01-10 08:23:43Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a condition that arises due to the formation of benign and malignant tumors in bones and connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas.

Read more ...

There is an increasing focus on alternative payment models for orthopaedic episodes of care. These models advance the goal of improving quality for Medicare beneficiaries and encourage collaboration throughout the full episode of care. CJR is a bundled paymentarrangement for 67 U.S. markets for total hip or total knee replacement surgeries, which are among the most common surgeries covered by Medicare. The SHFFT model is also a bundled payment arrangement for hospitals and clinicians that provides care to patients who receive surgery after a hip fracture. Approximately 258,000 people aged 65 and older were admitted for hip fractures in 20101. The estimated lifetime cost for all hip fractures in a single year is $20 billion2.

Read more ...

Willis-Knighton Health System in Shreveport, La., partnered with Johnson & Johnson Medical Device Companies. "As the market adopts more and more alternative payment models like orthopedic bundled payment programs, improving patient outcomes while driving costs down is vital to maintaining Willis-Knighton's status as one of the country's leading health systems," said Chris Magnin, physical medicine director of Willis-Knighton Health System. Here are five key notes: 1. The company announced CareAdvantage in conjunction with the Orthopaedic Episode of Care Approach. CareAdvantage is designed to provide a "holistic approach" to helping providers deliver better care. 2. Johnson & Johnson will offer the Orthopaedic Episode of Care Approach under their CareAdvantage capabilities.

Read more ...

Submit Community Content

If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!